Verdict91/ 100
Grade A− · #2Eden
A polished, high-disclosure compounded program with strong nationwide coverage.
Visit EdenHead-to-head verdict
Eden vs HealthRX
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
vs
Verdict86/ 100
Grade B · #8HealthRX
One of the few names that actually holds a LegitScript certification you can look up — and it pairs that with a rare oral GLP tablet and a fully published plan table, though the headline $99 and $179 rates are 12-month prepay floors, not what a month-to-month patient pays.
Visit HealthRXThe verdict
Winner: Eden
Eden takes it with a higher Verdict Score — 91/100 to 86/100 (grade A− vs B). People who prioritize a vetted, high-transparency provider over the lowest sticker price. HealthRX still earns its place — patients who want a verifiable, physician-supervised operator, would rather swallow a daily tablet than inject, and are willing to prepay a year to reach the lowest published rate.
Neither of these is our overall #1. That title goes to CoreAge Rx (94/100) — the most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
90Real-world results85
90
Real-world results85
89Price honesty85
89
Price honesty85
95Prescriber access89
95
Prescriber access89
86Formulary choice90
86
Formulary choice90
90Cancellation fairness84
90
Cancellation fairness84
92Member support84
92
Member support84
Price, coverage & features
| Metric | Eden | HealthRX |
|---|---|---|
| Verdict Score | 91/100 | 86/100 |
| Grade | A− | B |
| Semaglutide | $239/mo | $99/mo (annual) |
| Tirzepatide | $349/mo | $179/mo (annual) |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | No | Yes |
Eden
What we like
- High verification confidence — clear supply-chain and clinician disclosure
- Nationwide availability
- Both molecules offered
The caveats
- Premium pricing vs the cheapest tiers
- Compounded only — no brand-name access
HealthRX
What we like
- LegitScript-certified (#50087439) — a genuine, checkable trust signal, not a self-claim
- Physician-supervised intake with licensed prescribers
- Carries both molecules plus a rare oral GLP tablet — real route choice
- Full plan table published on-site with a current-as-of date: semaglutide $190/mo month-to-month down to $99/mo on the 12-month plan, tirzepatide $239/mo down to $179/mo — no insurance required
- Cancel online in one click, unshipped doses refunded, 30-day money-back guarantee and a full refund if a provider doesn't approve you
The caveats
- GLP-1 is compounded, not FDA-approved — the standard verification caveat applies
- The advertised $99 and $179 rates require a 12-month prepay — $1,188 and $2,148 up front; month-to-month runs $190 and $239
- Brand Ozempic is pass-through at ~$1,299/mo — the path exists but is priced out of reach for most
Our pick — visit
People who prioritize a vetted, high-transparency provider over the lowest sticker price.
Visit Eden Read the full Eden review →Also worth a look
Patients who want a verifiable, physician-supervised operator, would rather swallow a daily tablet than inject, and are willing to prepay a year to reach the lowest published rate.
Visit HealthRX Read the full HealthRX review →Keep comparing
Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.